EUVIMEDEUVIMED entdecken
Crossref

Clusters of risk factors for the development of comorbidity in patients with somatic pathology

E. V. Sevostyanova, Yu. A. Nikolaev, I. M. Mitrofanov, V. Ya. Polyakov, V. G. Selyatitskaya

Сибирский научный медицинский журнал · 07.01.2025 · 44 (6) · 218-224

DOI: 10.18699/ssmj20240623 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Сибирский научный медицинский журнал, online erschienen am 07.01.2025. Verfasst von E. V. Sevostyanova und 4 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The significant prevalence and severe medical and social consequences of comorbidity dictate the need to determine the etiopathogenetic risk factors that contribute to its formation. Purpose of the study: to study the associations of metabolic factors (arterial hypertension, obesity, hyperglycemia, dyslipidemia, hyperuricemia, increased serum concentration of C-reactive protein (CRP) with a high degree of comorbidity in patients with somatic pathology. Material and methods . An analytical retrospective study was carried out including data from the medical records of 5296 patients at a therapeutic clinic, men and women, aged from 18 to 92 years (56.4 ± 0.2 years). Comorbidity was taken into account in the presence of two or more nosologies in one patient, its degree was assessed by the number of nosologies in one patient. The following risk factors were assessed: arterial hypertension, obesity, hyperglycemia, dyslipidemia, hyperuricemia, increased concentration of CRP. The presence of non-alcoholic fatty liver disease (NAFLD) was also taken into account. The association of the considered factors with a high degree of comorbidity was assessed using logistic regression analysis. Results and discussion . The relations have been established between NAFLD, age over 52 years, female gender, as well as the considered metabolic factors with a high degree of comorbidity. NAFLD, age, obesity and hyperglycemia had the strongest associations with comorbidity. NAFLD increased the risk of developing a high degree of comorbidity by 5.6 times (odds ratio (OR) 5.59, 95 % confidence interval (CI) 4.40–7.11), age over 52 years – by 2.6 times (OR 2.60, 95 % CI 2.30–2.95); obesity – by 2.4 times (OR 2.37, 95 % CI 2.08–2.70), hyperglycemia – by 2.1 times (OR 2.05, 95 % CI 1.69–2. 49). Conclusions . The data obtained indicate the importance of NAFLD, as well as metabolic risk factors for CND, in increasing the likelihood of developing a high degree of comorbidity, which must be taken into account when developing programs for the prevention and treatment.

Zitieren

APA

Sevostyanova, E. V., Nikolaev, Y. A., Mitrofanov, I. M., Polyakov, V. Y., & Selyatitskaya, V. G. (2025). Clusters of risk factors for the development of comorbidity in patients with somatic pathology. Сибирский научный медицинский журнал, 44(6), 218-224. https://doi.org/10.18699/ssmj20240623

Vancouver

Sevostyanova EV, Nikolaev YA, Mitrofanov IM, Polyakov VY, Selyatitskaya VG. Clusters of risk factors for the development of comorbidity in patients with somatic pathology. Сибирский научный медицинский журнал. 2025;44(6):218-224. doi:10.18699/ssmj20240623

BibTeX
@article{Sevostyanova2025,
  author = {Sevostyanova, E. V. and Nikolaev, Yu. A. and Mitrofanov, I. M. and Polyakov, V. Ya. and Selyatitskaya, V. G.},
  title = {Clusters of risk factors for the development of comorbidity in patients with somatic pathology},
  journal = {Сибирский научный медицинский журнал},
  year = {2025},
  volume = {44},
  number = {6},
  pages = {218--224},
  doi = {10.18699/ssmj20240623}
}
Kostenlos starten →